The Yankee Candle Company, Inc., a leading manufacturer of premium scented candles, today announced the launch of new limited time holiday collection Snow Globes, featuring three new fragrances: Magical Frosted Forest, Sugary Sweet Snowfall and Santa’s Candy Castle™. Reflecting the nostalgia and magic of the season, this candle collection features classic holiday colors and snowy flurries that transport users to an enchanting winter wonderland.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61722-yankee-candle-holiday-snow-globes-collection-new-fragrances
Subaru of America, Inc. today introduced the all-new 2015 WRX STI, Subaru’s iconic performance flagship model, at the North American International Auto Show. Subaru will offer a WRX STI Launch Edition, limited to 1,000 units and exclusively featuring WR Blue paint and gold BBS® forged alloy wheels and unique interior trim.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/59482-subaru-of-america-2015-wrx-sti-launch-edition
Reflecting the transformative change happening at its properties, the iconic Marriott Hotels, the signature brand of Marriott International, Inc. (NYSE:MAR), today launched a new multi-year global marketing campaign. Called “Travel Brilliantly,” it is a bold move amplifying the brand’s dedication to leading the future of travel. The dynamic campaign reflects the lifestyle of the next generation of travelers, who seamlessly blend work and play in a mobile and global world. The campaign includes TV, digital and mobile advertising, a new brand look and logo, and enhanced social media platforms. In addition, Marriott is launching a new website – www.travelbrilliantly.com –revealing innovations under development, as well as a co-creation platform to solicit user-generated ideas.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54185-marriott-hotels-new-brand-logo-and-marketing-campaign
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
Buy on iTunes now: http://smarturl.it/tonightitunes
Website: http://www.kerianmusic.com
Twitter: https://www.twitter.com/KerianMusic
Facebook: https://www.facebook.com/KerianMusic
Music video by Kerian performing Tonight. (c) 2013 Ramiro Productions Inc.
The Jones Group Inc. (NYSE: JNY) today announced the launch of the QMack brand, a new collection focused on the millennial customer exclusively available at Macy’s and macys.com. The QMack collection is a wardrobing system that focuses on key items and classic shapes with a girly twist meant to be “mixed and macked” to create the ultimate, effortless uniform.
Inspired by all-American style, QMack also incorporates a global flair by way of Parisian and London influences to create classics with a twist in a multitude of colors and materials, including: go-to blazers, gathered minis, prep school skater skirts, roll sleeve blouses as well as easy dresses and cardigans. The name QMack was inspired by a composite of muses and the classic pieces they wore and then re-imagined to create a modern version for today. Prices range from $29 to $299.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62723-the-jones-group-inc-q-mack-new-uniform-for-millennials-macys
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today that the European Commission has granted marketing authorization to Constella® (linaclotide 290mcg) for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation (IBS-C) in adults . This approval follows the positive recommendation received from the European Committee for Medicinal Products for Human Use (CHMP) in September.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58658-almirall
Across the world millions of Mary Kay Independent Beauty Consultants, their customers, corporate employees and brand lovers will mark the golden anniversary and founding day of iconic beauty company Mary Kay.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63338-mary-kay-celebrates-50-anniversary-top-selling-beauty-company
Avon Products, Inc. today announced that Los Angeles Clippers basketball star Chris Paul will be joining the company’s team as the face of a new men’s fragrance, Untouchable. A legend in the making, Paul –husband, proud father of two and founder of the CP3 Foundation – represents the future of basketball and the power of the will to win. The new scent will capture the thrill of hitting the court when the crowd is going wild, sinking the game-winning shot and bringing home victory.
“The drive to win is what gets me out of bed every morning,” explains Paul. “This new scent with Avon will capture the competitive attitude that motivates me to play my best on and off the court.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/59630-avon-new-fragrance-untouchable-chris-paul-basketball-all-star
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced that it has acquired Ireland-based QUMAS, a leading global provider of Cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations in life sciences and other highly regulated industries. The QUMAS acquisition further extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions. Proven quality management solutions supported by robust content and business process management capabilities provided by QUMAS advance Accelrys’ ability to help customers better manage the scientific innovation lifecycle by reducing regulatory risks, lowering quality costs, improving compliance effectiveness and increasing operational efficiency in bringing new products to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62188-accelrys-acquires-compliance-and-quality-management-leader-qumas
The Amgen Foundation today announced $2.5 million in new grants for the Amgen Biotech Experience, an innovative science education program, bringing the total committed to nearly $8 million since the program’s inception in 1990. The Amgen Biotech Experience provides a real-world biotech lab experience to middle and high schools in Amgen’s U.S. and United Kingdom (U.K.) communities and will engage more than 50,000 students this year. Education Development Center, Inc. (EDC), a global nonprofit organization that creates learning opportunities around the world, has also been named Program Office to oversee the program’s implementation and facilitate its continued development.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/59861-amgen-biotech-experience-lab-science-education-grants-for-students
OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered Bi-Directional™ nasal technology. In a direct comparison of drug absorption, the study found that OptiNose's sumatriptan product sent 62% more drug into the blood in the critical first 15 minutes than Imitrex® nasal spray (AUC 0-15 = 1.69 ng*hr/mL and 1.04 ng*hr/mL, respectively). The OptiNose technology achieved this improved effect despite delivering 20% less drug into the nose (16mg) than the Imitrex® liquid nasal spray (20mg).
To view Multimedia News Release, go to http://www.multivu.com/players/English/57713-optinose-innovative-breath-powered-nasal-delivery-technology-delivers-drugs-to-treat-variety-of-medical-conditions
